EMEA (Europe, Middle East and Africa) Biosimilars of Monoclonal Antibody Market Report 2017

August 2017 | 117 pages | ID: EE02E8F4333EN
QYResearch

Abstracts

In this report, the EMEA Biosimilars of Monoclonal Antibody market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Biosimilars of Monoclonal Antibody for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biosimilars of Monoclonal Antibody market competition by top manufacturers/players, with Biosimilars of Monoclonal Antibody sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Roche
• Eli Lilly
• Bayer
• Amgen
• Sanofi-Aventis
• Johnson & Johnson
• Novo Nordisk
• Merck
• GSK
• BMS

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biosimilars of Monoclonal Antibody for each application, including

• Application 1
• Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Biosimilars of Monoclonal Antibody Market Report 2017

1 BIOSIMILARS OF MONOCLONAL ANTIBODY OVERVIEW

1.1 Product Overview and Scope of Biosimilars of Monoclonal Antibody
1.2 Classification of Biosimilars of Monoclonal Antibody
  1.2.1 EMEA Biosimilars of Monoclonal Antibody Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Biosimilars of Monoclonal Antibody Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.1 Type I
  1.2.2 Type II
1.3 EMEA Biosimilars of Monoclonal Antibody Market by Application/End Users
  1.3.1 EMEA Biosimilars of Monoclonal Antibody Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.1 Application
  1.3.2 Application
1.4 EMEA Biosimilars of Monoclonal Antibody Market by Region
  1.4.1 EMEA Biosimilars of Monoclonal Antibody Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biosimilars of Monoclonal Antibody (2012-2022)
  1.5.1 EMEA Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2022)

2 EMEA BIOSIMILARS OF MONOCLONAL ANTIBODY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Biosimilars of Monoclonal Antibody Market Competition by Players/Manufacturers
  2.1.1 EMEA Biosimilars of Monoclonal Antibody Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Biosimilars of Monoclonal Antibody Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Biosimilars of Monoclonal Antibody Sale Price by Players (2012-2017)
2.2 EMEA Biosimilars of Monoclonal Antibody (Volume and Value) by Type/Product Category
  2.2.1 EMEA Biosimilars of Monoclonal Antibody Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Biosimilars of Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Biosimilars of Monoclonal Antibody Sale Price by Type (2012-2017)
2.3 EMEA Biosimilars of Monoclonal Antibody (Volume) by Application
2.4 EMEA Biosimilars of Monoclonal Antibody (Volume and Value) by Region
  2.4.1 EMEA Biosimilars of Monoclonal Antibody Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Biosimilars of Monoclonal Antibody Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Biosimilars of Monoclonal Antibody Sales Price by Region (2012-2017)

3 EUROPE BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  3.1.1 Europe Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
3.2 Europe Biosimilars of Monoclonal Antibody Sales and Market Share by Type
3.3 Europe Biosimilars of Monoclonal Antibody Sales and Market Share by Application
3.4 Europe Biosimilars of Monoclonal Antibody Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Biosimilars of Monoclonal Antibody Sales Volume by Countries (2012-2017)
  3.4.2 Europe Biosimilars of Monoclonal Antibody Revenue by Countries (2012-2017)
  3.4.3 Germany Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  3.4.4 France Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  3.4.5 UK Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  3.4.6 Russia Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  3.4.7 Italy Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  4.1.1 Middle East Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
4.2 Middle East Biosimilars of Monoclonal Antibody Sales and Market Share by Type
4.3 Middle East Biosimilars of Monoclonal Antibody Sales and Market Share by Application
4.4 Middle East Biosimilars of Monoclonal Antibody Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Biosimilars of Monoclonal Antibody Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Biosimilars of Monoclonal Antibody Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  4.4.4 Israel Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  4.4.5 UAE Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  4.4.6 Iran Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)

5 AFRICA BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  5.1.1 Africa Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
5.2 Africa Biosimilars of Monoclonal Antibody Sales and Market Share by Type
5.3 Africa Biosimilars of Monoclonal Antibody Sales and Market Share by Application
5.4 Africa Biosimilars of Monoclonal Antibody Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Biosimilars of Monoclonal Antibody Sales Volume by Countries (2012-2017)
  5.4.2 Africa Biosimilars of Monoclonal Antibody Revenue by Countries (2012-2017)
  5.4.3 South Africa Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)

6 EMEA BIOSIMILARS OF MONOCLONAL ANTIBODY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi-Aventis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novo Nordisk
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novo Nordisk Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Merck
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 GSK
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Biosimilars of Monoclonal Antibody Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 GSK Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 BMS

7 BIOSIMILARS OF MONOCLONAL ANTIBODY MANUFACTURING COST ANALYSIS

7.1 Biosimilars of Monoclonal Antibody Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimilars of Monoclonal Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BIOSIMILARS OF MONOCLONAL ANTIBODY MARKET FORECAST (2017-2022)

11.1 EMEA Biosimilars of Monoclonal Antibody Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Biosimilars of Monoclonal Antibody Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Biosimilars of Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Biosimilars of Monoclonal Antibody Price and Trend Forecast (2017-2022)
11.2 EMEA Biosimilars of Monoclonal Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biosimilars of Monoclonal Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biosimilars of Monoclonal Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biosimilars of Monoclonal Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biosimilars of Monoclonal Antibody Sales Forecast by Type (2017-2022)
11.7 EMEA Biosimilars of Monoclonal Antibody Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilars of Monoclonal Antibody
Figure EMEA Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure EMEA Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Biosimilars of Monoclonal Antibody by Application in 2016
Figure Application 1 Examples
Table Key Downstream Customer in Application
Figure Application 2 Examples
Table Key Downstream Customer in Application
Figure EMEA Biosimilars of Monoclonal Antibody Market Size (Million USD) by Region (2012-2022)
Figure Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biosimilars of Monoclonal Antibody Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biosimilars of Monoclonal Antibody Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Sales Share by Players (2012-2017)
Figure 2016 Biosimilars of Monoclonal Antibody Sales Share by Players
Figure 2017 Biosimilars of Monoclonal Antibody Sales Share by Players
Figure EMEA Biosimilars of Monoclonal Antibody Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Revenue (Million USD) by Players (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Revenue Share by Players (2012-2017)
Table 2016 EMEA Biosimilars of Monoclonal Antibody Revenue Share by Players
Table 2017 EMEA Biosimilars of Monoclonal Antibody Revenue Share by Players
Table EMEA Biosimilars of Monoclonal Antibody Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilars of Monoclonal Antibody by Type (2012-2017)
Figure EMEA Biosimilars of Monoclonal Antibody Sales Market Share by Type (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilars of Monoclonal Antibody by Type in 2016
Table EMEA Biosimilars of Monoclonal Antibody Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilars of Monoclonal Antibody by Application (2012-2017)
Figure EMEA Biosimilars of Monoclonal Antibody Sales Market Share by Application in 2016
Table EMEA Biosimilars of Monoclonal Antibody Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilars of Monoclonal Antibody by Region (2012-2017)
Figure EMEA Biosimilars of Monoclonal Antibody Sales Market Share in 2016
Table EMEA Biosimilars of Monoclonal Antibody Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biosimilars of Monoclonal Antibody Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biosimilars of Monoclonal Antibody by Region (2012-2017)
Figure EMEA Biosimilars of Monoclonal Antibody Revenue Market Share Regions in 2016
Table EMEA Biosimilars of Monoclonal Antibody Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Sales (K Units) by Type (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Market Share by Type (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Market Share by Type in 2016
Table Europe Biosimilars of Monoclonal Antibody Sales (K Units) by Application (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Market Share by Application (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Market Share by Application in 2016
Table Europe Biosimilars of Monoclonal Antibody Sales (K Units) by Countries (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Sales Market Share by Countries in 2016
Table Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) by Countries (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Revenue Market Share by Countries in 2016
Figure Germany Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure France Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure UK Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biosimilars of Monoclonal Antibody Sales (K Units) by Type (2012-2017)
Table Middle East Biosimilars of Monoclonal Antibody Market Share by Type (2012-2017)
Figure Middle East Biosimilars of Monoclonal Antibody Market Share by Type (2012-2017)
Table Middle East Biosimilars of Monoclonal Antibody Sales (K Units) by Applications (2012-2017)
Table Middle East Biosimilars of Monoclonal Antibody Market Share by Applications (2012-2017)
Figure Middle East Biosimilars of Monoclonal Antibody Sales Market Share by Application in 2016
Table Middle East Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Biosimilars of Monoclonal Antibody Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biosimilars of Monoclonal Antibody Sales Volume Market Share by Countries in 2016
Table Middle East Biosimilars of Monoclonal Antibody Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biosimilars of Monoclonal Antibody Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilars of Monoclonal Antibody Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilars of Monoclonal Antibody Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biosimilars of Monoclonal Antibody Sales (K Units) by Type (2012-2017)
Table Africa Biosimilars of Monoclonal Antibody Sales Market Share by Type (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Sales Market Share by Type (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Sales Market Share by Type in 2016
Table Africa Biosimilars of Monoclonal Antibody Sales (K Units) by Application (2012-2017)
Table Africa Biosimilars of Monoclonal Antibody Sales Market Share by Application (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Sales Market Share by Application (2012-2017)
Table Africa Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Countries (2012-2017)
Table Africa Biosimilars of Monoclonal Antibody Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Sales Market Share by Countries in 2016
Table Africa Biosimilars of Monoclonal Antibody Revenue (Million USD) by Countries (2012-2017)
Table Africa Biosimilars of Monoclonal Antibody Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilars of Monoclonal Antibody Revenue Market Share by Countries in 2016
Figure South Africa Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Biosimilars of Monoclonal Antibody Basic Information List
Table Pfizer Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Roche Biosimilars of Monoclonal Antibody Basic Information List
Table Roche Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Biosimilars of Monoclonal Antibody Basic Information List
Table Eli Lilly Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Bayer Biosimilars of Monoclonal Antibody Basic Information List
Table Bayer Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Amgen Biosimilars of Monoclonal Antibody Basic Information List
Table Amgen Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Basic Information List
Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biosimilars of Monoclonal Antibody Basic Information List
Table Johnson & Johnson Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Biosimilars of Monoclonal Antibody Basic Information List
Table Novo Nordisk Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table Merck Biosimilars of Monoclonal Antibody Basic Information List
Table Merck Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table GSK Biosimilars of Monoclonal Antibody Basic Information List
Table GSK Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Sales Market Share in EMEA (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Revenue Market Share in EMEA (2012-2017)
Table BMS Biosimilars of Monoclonal Antibody Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars of Monoclonal Antibody
Figure Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody
Figure Biosimilars of Monoclonal Antibody Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Manufacturers in 2016
Table Major Buyers of Biosimilars of Monoclonal Antibody
Table Distributors/Traders List
Figure EMEA Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biosimilars of Monoclonal Antibody Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Biosimilars of Monoclonal Antibody Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Biosimilars of Monoclonal Antibody Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilars of Monoclonal Antibody Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Biosimilars of Monoclonal Antibody Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilars of Monoclonal Antibody Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Biosimilars of Monoclonal Antibody Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources